Table 2.
Outcomes of CT-guided percutaneous radiofrequency ablation.
| Outcomes | |
|---|---|
| Mortality | 0% | 
| Intraprocedural hypertension over 180 mmHg | 43.2% | 
| Adverse events | |
| Grade 3 | 26.3% | 
| Grade 4 | 2.6% | 
| Grade 5 | 0% | 
| Treatment success rate | |
| Percentage of complete tumor ablation on CT scan, (%) | 94.6% | 
| Percentage of aldosterone normalization rate at 84 days, (%) | 86.5% | 
| The number of types of antihypertensive drugs | |
| Day 0 | 1.6 ± 1.3 | 
| Day 84 | 0.5 ± 0.7 | 
CT Computed tomography.